Liquidia Corp (LQDA) stock
LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3079% above fair value
$54.43−2.20 (-3.88%)
Close on Nov 20, 2026Market cap $4.87BP/E 39.2Yield –
Liquidia free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Liquidia's free cash flow for the twelve months ending Jun 30, 2026 was $150.69M. For fiscal 2025 it was -$40.02M. The highest annual figure on record is -$29.18M in fiscal 2022.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$40.02M | – |
| FY2024 | Dec 31, 2024 | -$98.37M | – |
| FY2023 | Dec 31, 2023 | -$42.85M | – |
| FY2022 | Dec 31, 2022 | -$29.18M | – |
| FY2021 | Dec 31, 2021 | -$34.14M | – |
| FY2020 | Dec 31, 2020 | -$54.90M | – |
| FY2019 | Dec 31, 2019 | -$50.13M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $69.01M | – |
| Q1 FY2026 | Mar 31, 2026 | $50.16M | – |
| Q4 FY2025 | Dec 31, 2025 | $42.21M | – |
| Q3 FY2025 | Sep 30, 2025 | -$10.68M | – |
| Q2 FY2025 | Jun 30, 2025 | -$40.54M | – |
| Q1 FY2025 | Mar 31, 2025 | -$31.01M | – |
| Q4 FY2024 | Dec 31, 2024 | -$22.10M | – |
| Q3 FY2024 | Sep 30, 2024 | -$26.83M | – |
| Q2 FY2024 | Jun 30, 2024 | -$23.95M | – |
| Q1 FY2024 | Mar 31, 2024 | -$25.49M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.19M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.04M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.81M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.82M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.09M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.87M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.44M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.78M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.58M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.83M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.29M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.44M | – |
| Q4 FY2020 | Dec 31, 2020 | -$14.13M | – |
| Q3 FY2020 | Sep 30, 2020 | -$12.63M | – |
| Q2 FY2020 | Jun 30, 2020 | -$13.52M | – |
| Q1 FY2020 | Mar 31, 2020 | -$14.62M | – |
See a number that looks wrong?